Comparison of β-blocker agents and mortality in maintenance hemodialysis patients: an international cohort study.

Corey ToyeManish M SoodRanjeeta MallickAyub AkbariBrian BieberAngelo KaraboyasMurilo GuedesGregory L Hundemer

Published in: Clinical kidney journal (2024)

Among patients on maintenance hemodialysis who were newly prescribed β-blocker medications, atenolol was associated with the lowest mortality risk compared with alternative agents.

Keyphrases

angiotensin converting enzyme
cardiovascular events
chronic kidney disease
peritoneal dialysis
risk factors
type diabetes
cardiovascular disease